Here, CD133 expression increased after chemotherapy in mouse and human SCLC, with the latter having been confirmed in clinical specimens from a patient receiving chemotherapy—providing evidence of the intrinsic tolerance of CSCs to chemotherapeutics [23]. The gene discussed is PROM1; the disease is small cell lung carcinoma.